CT
IBB icon

Colonial Trust’s iShares Biotechnology ETF IBB Stock Holding History

Colonial Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
8,802
-200
-2% -$34.2K 0.2% 107
2025
Q4 		$1.52M Sell
9,002
-860
-9% -$140K 0.2% 104
2025
Q3 		$1.42M Sell
9,862
-114
-1% -$15.6K 0.19% 109
2025
Q2 		$1.26M Sell
9,976
-657
-6% -$80.7K 0.18% 110
2025
Q1 		$1.36M Sell
10,633
-271
-2% -$36.7K 0.21% 102
2024
Q4 		$1.44M Buy
10,904
+645
+6% +$90.7K 0.21% 97
2024
Q3 		$1.49M Sell
10,259
-608
-6% -$88K 0.23% 96
2024
Q2 		$1.49M Sell
10,867
-139
-1% -$18.6K 0.26% 86
2024
Q1 		$1.51M Sell
11,006
-361
-3% -$49.3K 0.28% 83
2023
Q4 		$1.54M Sell
11,367
-343
-3% -$41.8K 0.32% 77
2023
Q3 		$1.43M Sell
11,710
-733
-6% -$93.2K 0.35% 71
2023
Q2 		$1.58M Buy
12,443
+80
+0.6% +$10.4K 0.38% 69
2023
Q1 		$1.6M Sell
12,363
-202
-2% -$26.4K 0.41% 66
2022
Q4 		$1.65M Buy
12,565
+415
+3% +$53.6K 0.45% 63
2022
Q3 		$1.42M Buy
+12,150
New +$1.51M 0.45% 64

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Colonial Trust's IBB Position: Q1 2026 in Review

Colonial Trust reduced its iShares Biotechnology ETF (IBB) stake by 2.2% in Q1 2026, selling an estimated $34.2K and leaving 8,802 shares worth $1.49M. The position accounts for 0.2% of the portfolio, ranked #107.

Colonial Trust first reported a position in IBB in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.65M in Q4 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Colonial Trust held 8,802 shares of iShares Biotechnology ETF worth $1.49M as of Q1 2026.
  • Colonial Trust sold 200 iShares Biotechnology ETF shares in Q1 2026, an estimated $34.2K.
  • iShares Biotechnology ETF made up 0.2% of Colonial Trust's portfolio in Q1 2026, its #107 holding.
  • Colonial Trust first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 15 quarters since.
  • Colonial Trust's iShares Biotechnology ETF position peaked at $1.65M in Q4 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.